Press Releases

Taconic Biosciences to Distribute Critical COVID-19 Mouse Model

Taconic Biosciences to Distribute Critical COVID-19 Mouse Model

Signs Exclusive Agreement with University of Texas Medical Branch at Galveston to Access Humanized ACE2 Mouse Model Rensselaer, NY — June 22, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an exclusive agreement with the University of Texas Medical Branch at Galveston (UTMB) to distribute humanized ACE2 mice for coronavirus research. The SARS-CoV-2 virus, which causes COVID-19, uses the ACE2...  Read More

Taconic Biosciences Expands Production of Critical Immunodeficient Model

Taconic Biosciences Expands Production of Critical Immunodeficient Model

Local Production of the CIEA NOG mouse® Model Now Available on the West Coast Rensselaer, NY, — June 10, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces local West Coast United States production of the immunodeficient CIEA NOG mouse® model. Immunodeficient animal models are critical to the drug discovery ecosystem. One of the most common contributors to the high product...  Read More

Taconic Biosciences Launches Rapid Restart™ Program

Taconic Biosciences Launches Rapid Restart™ Program

First Animal Model Provider to Create Program Aiding Researchers Planning for Return Rensselaer, NY, — May 18, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid Restart™ program. Launched over a month ago, Taconic was the first animal model provider in the industry to provide researchers with a program specifically designed to aid laboratories transitioning...  Read More

Taconic Biosciences Supports Coronavirus Research

Taconic Biosciences Supports Coronavirus Research

Announces Preclinical COVID-19 Research Tools Rensselaer, NY — March 20, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts via a new Coronavirus Toolkit featuring relevant models and services. Mouse models have been extensively used for research on the SARS-CoV virus, closely related to the new SARS-CoV-2 virus that causes COVID-19. Taconic offers many animal...  Read More

Taconic Biosciences Expands Humanized Mouse Model Production

Taconic Biosciences Expands Humanized Mouse Model Production

Local Production of Critical Immuno-oncology Models Now Available in Europe Rensselaer, NY — February 14, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now being produced in Europe. Local production provides European drug discovery researchers with easier access to this critical oncology research tool. Humanized immune system mice enable drug discovery research by...  Read More

Taconic Biosciences Launches New Immuno-oncology Mouse Model

Taconic Biosciences Launches New Immuno-oncology Mouse Model

Expands and Broadens Taconic Biosciences' Immuno-oncology Portfolio Application Rensselaer, NY — January 31, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model. Immuno-oncology leverages the body's immune system to fight cancer, increasing the ability to target the disease. Animal models used in this therapeutic development include special mice,...  Read More

Taconic Biosciences Opens New Model Generation Facility

Taconic Biosciences Opens New Model Generation Facility

New State-of-the-Art Laboratories in Leverkusen, Germany Rensselaer, NY — January 13, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, opened a new model generation facility in Leverkusen, Germany. This location houses model generation services, replacing the previous Taconic site in Cologne, Germany. Custom genetically modified animal models are critical to the drug discovery process. Taconic leads the industry in providing model...  Read More

Taconic Biosciences Announces New San Diego Location

Taconic Biosciences Announces New San Diego Location

Local Commercial Animal Model Production and Colony Management Services Available to West Coast Customers Rensselaer, NY — January 2, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the availability of both commercial animal model production and colony management services through a new location in San Diego. Taconic can now provide critical drug discovery research solutions locally to west coast customers....  Read More

Taconic Biosciences Launches Alzheimer's Disease Mouse Model

Taconic Biosciences Launches Alzheimer's Disease Mouse Model

Proven Model Available Exclusively From Taconic Biosciences Rensselaer, NY — November 4, 2019 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer's disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes. This combination manifests in early...  Read More

Taconic Biosciences Announces New Scientific Advisory Board Member

Taconic Biosciences Announces New Scientific Advisory Board Member

Dr. Frank Sistare Joins Taconic Biosciences' Scientific Advisory Board Rensselaer, NY — October 17, 2019 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the addition of Frank Sistare, PhD to its Scientific Advisory Board (SAB). Dr. Sistare joins existing SAB members Andrew Goodman, PhD, David Hill, PhD, and Robert Rosenthal, PhD. The SAB will continue to collaborate with Taconic's management in...  Read More